Of note, miR-323a-5p overexpression impaired tumor growth in the MYCN-amplified cell line, but not in SK-N-AS, suggesting that higher doses of miR-323a-5p or being functional for longer periods of time may be needed to achieve a therapeutic effect. The gene discussed is MYCN; the disease is neoplasm.